Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Taramasso

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
Vaccines|July 27, 2022
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease ProgressionAntonio Vena, Luca Traman, Martina Bavastro, et al.
Frontiers in Immunology|May 13, 2022
Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral TreatmentLucia Taramasso, Federica Bozzano, Anna Casabianca, et al.
AIDS (London, England)|May 8, 2025
Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infectionSabrina Marozin, Valeria Bono, Martina Mazzoccoli, et al.
The Journal of Antimicrobial Chemotherapy|May 12, 2025
Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in ItalyAlessandro Cozzi-Lepri, Alessandro Tavelli, Lucia Taramasso, et al.
The New Microbiologica|October 27, 2025
Shifting antiretroviral drug distribution from Outpatient Clinics to Hospital Pharmacies in Italy. Evolution of ART delivery methods and impact on treatment adherenceLucia Taramasso, Giorgia Brucci, Silvia Dettori, et al.
Journal of Global Antimicrobial Resistance|October 13, 2025
96-week real-world effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in HIV-infected adults with pre-existing NRTI resistance: A retrospective cohort studyLaura Mezzogori, Marco Muccio, Riccardo Schiavoni, et al.
Antiviral Therapy|June 26, 2014
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV statusLaura A Nicolini, Lucia Taramasso, Irene Schiavetti, et al.
Iscience|January 8, 2024
Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIVMatteo Augello, Valeria Bono, Roberta Rovito, et al.
ERJ Open Research|February 8, 2018
Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharingNiccolò Riccardi, Barbara Giannini, Maria Lucia Borghesi, et al.
Journal of Nephrology|October 7, 2020
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern ItalyElisa Russo, Pasquale Esposito, Lucia Taramasso, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
Vaccines|July 27, 2022
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease ProgressionAntonio Vena, Luca Traman, Martina Bavastro, et al.
Frontiers in Immunology|May 13, 2022
Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral TreatmentLucia Taramasso, Federica Bozzano, Anna Casabianca, et al.
AIDS (London, England)|May 8, 2025
Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infectionSabrina Marozin, Valeria Bono, Martina Mazzoccoli, et al.
The Journal of Antimicrobial Chemotherapy|May 12, 2025
Selected comorbidities and the probability of ART switch in PWH with undetectable HIV-RNA: a retrospective analysis in ItalyAlessandro Cozzi-Lepri, Alessandro Tavelli, Lucia Taramasso, et al.
The New Microbiologica|October 27, 2025
Shifting antiretroviral drug distribution from Outpatient Clinics to Hospital Pharmacies in Italy. Evolution of ART delivery methods and impact on treatment adherenceLucia Taramasso, Giorgia Brucci, Silvia Dettori, et al.
Journal of Global Antimicrobial Resistance|October 13, 2025
96-week real-world effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in HIV-infected adults with pre-existing NRTI resistance: A retrospective cohort studyLaura Mezzogori, Marco Muccio, Riccardo Schiavoni, et al.
Antiviral Therapy|June 26, 2014
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV statusLaura A Nicolini, Lucia Taramasso, Irene Schiavetti, et al.
Iscience|January 8, 2024
Association between SARS-CoV-2 RNAemia, skewed T cell responses, inflammation, and severity in hospitalized COVID-19 people living with HIVMatteo Augello, Valeria Bono, Roberta Rovito, et al.
ERJ Open Research|February 8, 2018
Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharingNiccolò Riccardi, Barbara Giannini, Maria Lucia Borghesi, et al.
Journal of Nephrology|October 7, 2020
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern ItalyElisa Russo, Pasquale Esposito, Lucia Taramasso, et al.
Pageof 14